Drug firm MSD has decided to enter into voluntary licensing agreements for investigational oral antiviral drug candidate 'Mmolnupiravir', which is being studied for the treatment of Covid-19, with......
The Reserve Bank of India (RBI) on Wednesday met the long-standing demand of banks by allowing them to finance acquisitions by Indian companies, a move that also expands banks’ capital market......
India’s pharmaceuticals and medical devices industries are still hopeful that trade negotiations with the US could cut a fairer deal for both sides, after President Donald Trump announced a 25......
The more things change, the more they remain the same for corporate India. Illustration: Dominic Xavier/Rediff In the April-June 2025 period (Q1FY26) — for the ninth consecutive quarter —......
Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it may face increased drug shortages if tariffs are imposed on such imports.......
Indian pharmaceutical companies may have units abroad as part of “distributed manufacturing” across various locations, according to industry veterans. Illustration: Uttam......